Mehrotra A and Sandhir R |
Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation. |
2014 |
Behav. Brain Res. |
pmid:24393741
|
Liu J et al. |
Reloading functionally ameliorates disuse-induced muscle atrophy by reversing mitochondrial dysfunction, and similar benefits are gained by administering a combination of mitochondrial nutrients. |
2014 |
Free Radic. Biol. Med. |
pmid:24418157
|
Zhang H et al. |
Metabolomic analysis of biochemical changes in the plasma and urine of collagen-induced arthritis in rats after treatment with Huang-Lian-Jie-Du-Tang. |
2014 |
J Ethnopharmacol |
pmid:24709313
|
Jiang Q et al. |
Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine. |
2013 Sep-Oct |
Ann Hepatol |
pmid:24018499
|
Cuevas E et al. |
Acetyl L-carnitine protects motor neurons and Rohon-Beard sensory neurons against ketamine-induced neurotoxicity in zebrafish embryos. |
2013 Sep-Oct |
Neurotoxicol Teratol |
pmid:23896048
|
Kathirvel E et al. |
Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. |
2013 |
Nutr Res |
pmid:24176233
|
Russo SJ and Charney DS |
Next generation antidepressants. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:23471996
|
Lodi A et al. |
Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active disease. |
2013 |
PLoS ONE |
pmid:23431376
|
Zuena AR et al. |
Transplacental exposure to AZT induces adverse neurochemical and behavioral effects in a mouse model: protection by L-acetylcarnitine. |
2013 |
PLoS ONE |
pmid:23409035
|
Nasca C et al. |
L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:23382250
|